IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soloway, M. R.
Right arrow Articles by Sears, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soloway, M. R.
Right arrow Articles by Sears, M.

Investigative Ophthalmology & Visual Science, Vol 20, 47-52, Copyright © 1981 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

The miotic effect of substance P on the isolated rabbit iris

MR Soloway, J Stjernschantz and M Sears

The effect of substance P on the rabbit iris was investigated by continuously monitoring the pupil size in vitro. Continuous perfusion with substance P caused a concentration-dependent contraction of the iridial sphincter muscle. The threshold was 2 x 10(-10) M. A concentration-response curve was made for 60 sec exposures of the iris to substance P. Blockade of muscarinic, nicotinic, alpha-, and beta- adrenergic receptors as well as blockade with the putative presynaptic substance P-blocking agent baclofen did not affect the constrictor response to substance P. Pretreatment of the rabbits with indomethacin was also without effect. No effect of substance P was seen on the isolated iridial dilator muscle. Although the miotic response to substance P was observed in a calcium-free perfusion fluid, EGTA added to calcium-free perfusate diminished the effect of substance P. The response of the iris to substance P and the time course of the response make it likely that substance P is involved in the miosis of the nerve- mediated irritative response of the eye.


This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
N Yamada, R Matsuda, N Morishige, R Yanai, T-i Chikama, T Nishida, T Ishimitsu, and A Kamiya
Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy
Br. J. Ophthalmol., July 1, 2008; 92(7): 896 - 900.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Yamada, R. Yanai, K. Kawamoto, T. Nagano, M. Nakamura, M. Inui, and T. Nishida
Promotion of Corneal Epithelial Wound Healing by a Tetrapeptide (SSSR) Derived from IGF-1.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3286 - 3292.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Yamada, R. Yanai, M. Nakamura, M. Inui, and T. Nishida
Role of the C Domain of IGFs in Synergistic Promotion, with a Substance P-Derived Peptide, of Rabbit Corneal Epithelial Wound Healing
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1125 - 1131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Association for Research in Vision and Ophthalmology